Zobrazeno 1 - 10
of 115
pro vyhledávání: '"Marie Louise Michel"'
Autor:
Simone Bocchetta, Patrick Maillard, Mami Yamamoto, Claire Gondeau, Florian Douam, Stéphanie Lebreton, Sylvie Lagaye, Stanislas Pol, François Helle, Wanee Plengpanich, Maryse Guérin, Maryline Bourgine, Marie Louise Michel, Dimitri Lavillette, Philippe Roingeard, Wilfried le Goff, Agata Budkowska
Publikováno v:
PLoS ONE, Vol 9, Iss 3, p e92140 (2014)
Hepatitis C virus (HCV) establishes infection using host lipid metabolism pathways that are thus considered potential targets for indirect anti-HCV strategies. HCV enters the cell via clathrin-dependent endocytosis, interacting with several receptors
Externí odkaz:
https://doaj.org/article/ea0a015d59e3455fb82fb06bdab41c39
Publikováno v:
Biotecnología Aplicada, Vol 34, Iss 2, Pp 2511-2521 (2017)
Externí odkaz:
https://doaj.org/article/938ef1f163d74780aafd524fe0e4bcbe
Autor:
Marie-Louise Michel
Publikováno v:
Hépatite B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::689231beeb18f934b6c84b0d3bc9290f
https://doi.org/10.1051/978-2-84254-223-8-010
https://doi.org/10.1051/978-2-84254-223-8-010
Autor:
Camille Sureau, Verena Hehle, Oriane Fiquet, Cyril Planchais, Valérie Lorin, Marie-Louise Michel, Jordan D. Dimitrov, Helene Strick-Marchand, Nadege Pelletier, Stanislas Pol, Maxime Beretta, Hugo Mouquet, Thierry Hieu, Malika Ait-Goughoulte, James P. Di Santo, Andrea Stauffer, Marie-Noëlle Ungeheuer, Maryline Bourgine, Benjamin Vesin, Solen Morisse
Publikováno v:
Journal of Experimental Medicine
Journal of Experimental Medicine, 2020, 217 (10), pp.e20200840. ⟨10.1084/jem.20200840⟩
Journal of Experimental Medicine, Rockefeller University Press, 2020, 217 (10), pp.e20200840. ⟨10.1084/jem.20200840⟩
Journal of Experimental Medicine, 2020, 217 (10), pp.e20200840. ⟨10.1084/jem.20200840⟩
Journal of Experimental Medicine, Rockefeller University Press, 2020, 217 (10), pp.e20200840. ⟨10.1084/jem.20200840⟩
International audience; Rare individuals can naturally clear chronic hepatitis B virus (HBV) infection and acquire protection from reinfection as conferred by vaccination. To examine the protective humoral response against HBV, we cloned and characte
Autor:
Marie-Louise, Michel
Publikováno v:
Virologie (Montrouge, France). 18(1)
More than two billions individuals are with serological markers of a recent or past hepatitis B virus (HBV) infection. Vaccination is the most efficient way to prevent new infections and in this matter, vaccines have been available for more than 30 y
Autor:
Laura Sepp-Lorenzino, Stuart Milstein, Carolin Mogler, Jinpeng Su, Till Bunse, Anna D. Kosinska, Dirk Grimm, Marie-Louise Michel, Julia Festag, Mathias Heikenwalder, Thomas Michler, Marc Ringelhan, Percy A. Knolle, Carlos A. Guzmán, Katja Steiger, Hortenzia Imhof, Ulrike Protzer
Publikováno v:
Gastroenterology 158, 1762-1775 (2020)
Background & Aims Hepatitis B virus (HBV) infection persists because the virus-specific immune response is dysfunctional. Therapeutic vaccines might be used to end immune tolerance to the virus in patients with chronic infection, but these have not b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9ca44cd7036e02a06bdfa14d600dfeb
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=58800
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=58800
Autor:
Yadira Lobaina, Julio C Aguilar, Marie-Louise Michel, Maryline Bourgine, Gerardo Guillén, Sandrine Crabe
Publikováno v:
Antiviral Research. 153:23-32
Immunization routes and number of doses remain largely unexplored in therapeutic vaccination. The aim of the present work is to evaluate their impact on immune responses in naive and hepatitis B virus (HBV)-carrier mouse models following immunization
Autor:
Thomas F. Baumert, Xavier Marniquet, Pierre Cortez, Laurent Mailly, Anna Salvetti, François-Loïc Cosset, Fabien Zoulim, Aurore Inchauspé, Barbara Testoni, Massimo Levrero, Julie Lucifora, David Durantel, Floriane Fusil, Maud Michelet, C Challier, Marie-Louise Michel
Publikováno v:
Antiviral Research
Antiviral Research, 2017, 145, pp.14-19. ⟨10.1016/j.antiviral.2017.07.006⟩
Antiviral Research, Elsevier Masson, 2017, 145, pp.14-19. ⟨10.1016/j.antiviral.2017.07.006⟩
Antiviral Research, 2017, 145, pp.14-19. ⟨10.1016/j.antiviral.2017.07.006⟩
Antiviral Research, Elsevier Masson, 2017, 145, pp.14-19. ⟨10.1016/j.antiviral.2017.07.006⟩
International audience; Hepatitis B Virus (HBV) persists in infected hepatocytes as an episomal covalently-closed-circular DNA mini-chromosome, called cccDNA. As the main nuclear transcription template, HBV cccDNA is a key replication intermediate in
Autor:
Marie-Louise Michel, Yadira Lobaina
Publikováno v:
Vaccine. 35:2308-2314
More than 250 million people worldwide are chronically infected with hepatitis B virus (CHB), and over half a million die each year due to CHB-associated liver complications such as cirrhosis and hepatocellular carcinoma. The translation of immunolog
Autor:
Masahito Shimizu, Jamila Faivre, Kubra Altinel, Christine Neuveut, Hitoshi Ikeda, Harukazu Suzuki, Tomokazu Matsuura, Tian Xia, Yu Wei, Ana Maria Suzuki, Yasuhiro Takikawa, Soichi Kojima, Alexandre Dos Santos, Didier Samuel, Isao Hidaka, Ishita Gupta, Sachi Kato, Akihito Tsubota, Pierrick Moreau, Marie-Louise Michel, Sumiko Nagoshi, Piero Carninci, Marie Annick Buendia, Kosuke Hashimoto
Publikováno v:
Journal of Virology
Hepatitis B virus (HBV) is a major cause of liver diseases, including hepatocellular carcinoma (HCC), and more than 650,000 people die annually due to HBV-associated liver failure. Extensive studies of individual promoters have revealed that heteroge